Bhupathy Alagiriswamy

Local Study Associate Director - AstraZeneca

Bhupathy Alagiriswamy


  • Tuesday - May 10, 2022 - 10:15

    Executives Discussion and Debate: How AI and Machine Learning is driving value for Global Pharma

    • Innovation in Big-Pharma
    • AI enabled business models in R&D
    • Achieving full potential of AI to boost Drug Discovery and Development
    • AI has the capacity to radically reduce the uncertainty in both early and late-stage drug discovery and development


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now